Study: Treat-to-Target Success in Early RA Is Durable

Source link :

Success with “treat-to-target” therapy for early-stage rheumatoid arthritis (RA) lasted up to 20 years, according to researchers who followed up with participants in two of the first clinical trials aimed at testing the strategy. Most patients in the trials — which aimed at drug-free remission in one, low disease activity in the other — had […]

Author : News Health

Publish date : 2024-04-04 17:24:34

Copyright for syndicated content belongs to the linked Source.